State Street SPDR S&P Biotech ETF (XBI)

NYSE Arca
$140.18-2.73%As of 2026-11-22 · USD
Last session low $139.87Last session high $145.48
52-week low $117.1152-week high $169.89
Dividend yield
0.35%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)39.1In the neutral range (30 to 70)
MACD (12, 26, 9)-2.28Below its signal line (-1.16); histogram -1.11
Bollinger %B (20, 2)-10%Below the lower band (142.10 to 161.64)
SMA 20151.87Price is 7.7% below
SMA 50152.78Price is 8.2% below
SMA 200143.40Price is 2.2% below
ATR (20)3.36% of priceAverage true range per day
52-week position44%In the middle of the 117.11 to 169.89 range

About State Street SPDR S&P Biotech ETF

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

More Health ETFs